Drugs / Volonib
last change Dec 2024 re-read 2 minutes ago

Volonib

Developed for
renal carcinoma
Investigated by
Sun Yat-sen University

Trials 1 · a red edge is where a trial was stopped

2025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06730672 Dec 2024 → Dec 2027 expected renal carcinoma Sun Yat-sen University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Volonib ClinicalTrials.gov intervention name — accepted as the source's own label NCT06730672